APA (7th ed.) Citation

Xiao, Y., Yu, Y., Jiang, P., Li, Y., Wang, C., & Zhang, R. (2020). The PI3K/mTOR dual inhibitor GSK458 potently impedes ovarian cancer tumorigenesis and metastasis. Cellular Oncology (2211-3428), 43(4), 669. https://doi.org/10.1007/s13402-020-00514-8

Chicago Style (17th ed.) Citation

Xiao, Yangjiong, Yang Yu, Pengcheng Jiang, Yuhong Li, Chao Wang, and Rong Zhang. "The PI3K/mTOR Dual Inhibitor GSK458 Potently Impedes Ovarian Cancer Tumorigenesis and Metastasis." Cellular Oncology (2211-3428) 43, no. 4 (2020): 669. https://doi.org/10.1007/s13402-020-00514-8.

MLA (9th ed.) Citation

Xiao, Yangjiong, et al. "The PI3K/mTOR Dual Inhibitor GSK458 Potently Impedes Ovarian Cancer Tumorigenesis and Metastasis." Cellular Oncology (2211-3428), vol. 43, no. 4, 2020, p. 669, https://doi.org/10.1007/s13402-020-00514-8.